Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Messages, Profile, Reports, Research, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 16)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
6-Feb-10 Reuters Investment Profile N/A Dr Reddys Laboratories Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for RDY: the economy's impact on RDY's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: DR REDDY'S LABORATORIES LTD 5 $25 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: DR REDDY'S LABORATORIES LTD 5 $25 View Abstract
20-Jan-10 Thomson StreetEvents N/A RDY - Event Transcript of Dr. Reddy's Laboratories Ltd. conference call, Jan. 20, 2010 / 6:30pm ET 30 $75 View Abstract
17-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: DR REDDY'S LABORATORIES LTD 5 $25 View Abstract
4-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: DR REDDY'S LABORATORIES LTD 5 $25 View Abstract
27-Dec-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: DR REDDY'S LABORATORIES LTD 5 $25 View Abstract
Next 6

Brokerage Reports (Showing 1 to 1 of 1)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
20-Jan-10 Thomson StreetEvents N/A RDY - Event Transcript of Dr. Reddy's Laboratories Ltd. conference call, Jan. 20, 2010 / 6:30pm ET 30 $75 View Abstract

Independent Reports (Showing 1 to 10 of 15)

Release
Date Contributor Author Title Pages Price More Info
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
6-Feb-10 Reuters Investment Profile N/A Dr Reddys Laboratories Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for RDY: the economy's impact on RDY's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: DR REDDY'S LABORATORIES LTD 5 $25 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: DR REDDY'S LABORATORIES LTD 5 $25 View Abstract
17-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: DR REDDY'S LABORATORIES LTD 5 $25 View Abstract
4-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: DR REDDY'S LABORATORIES LTD 5 $25 View Abstract
27-Dec-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: DR REDDY'S LABORATORIES LTD 5 $25 View Abstract
30-Mar-09 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
Next 5

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.